Sintilimab Plus FOLFIRI as Salvage Therapy for Patients With Advanced Gastric Cancer
Conditions: Unresectable/Metastatic Gastric Cancer Interventions: Drug: Sintilimab+irinotecan+leucovorin folinate+fluorouracil Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | Hospitals | Research